1 Min Read
* ONXEO INTRODUCES PLATON™, A PROPRIETARY CHEMISTRY PLATFORM OF DECOY OLIGONUCLEOTIDES
* PLATON™ WILL GENERATE NEW BEST-IN-CLASS DNA-TARGETING DRUG CANDIDATES STARTING IN 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.